Publications
Unitaid’s online library includes, among other things, stories about our impact, summaries of our grant portfolios, technical reports and resolutions from the Unitaid Board.
Find a Document
June 2023
R12-2023-e Additional funding for the Project ‘Late-Stage Development and Regulatory Approval of the Vayu bCPAP and Low-Flow Blender Circuit Devices’
Document Type
e-Resolutions
June 2023
R11-2023-e Additional ACT-A investment for the Project “Tools for Integrated Management of Childhood Illness – TIMCI”
Document Type
e-Resolutions
June 2023
R10-2023-e No-cost extension for COVID-19 Output in the project entitled “Rapid, comprehensive targeted gene sequencing solution for drug-resistant TB diagnosis in LMICs”
Document Type
e-Resolutions
June 2023
R9-2023-e Additional ACT-A investments to accelerate and expand Unitaid’s support for the development and introduction of molecular diagnostics
Document Type
e-Resolutions
June 2023
R8-2023-e Extension of authorization to procure COVID-19 therapeutics, with reallocation of unspent ACT-A funds to Unitaid’s Medical Oxygen Portfolio
Document Type
e-Resolutions
June 2023
R14-2023-e Cost Extension for the Project “Broad One Health Endectocide-based Malaria Intervention in Africa” (BOHEMIA)
Document Type
e-Resolutions
June 2023
R13-2023-e Extension for the Project “Rapid, comprehensive targeted gene sequencing solution for drug-resistant TB diagnosis in LMICs”
Document Type
e-Resolutions
June 2023
Unitaid Audited Financial Report for the year ended 31 December 2022
Document Type
Financial Statement
No results could be found. Try refining your filters.
December 2022
R20-2022-e Innovate, Involve, Inspire: Preventing Hepatitis C Through Community-Led Harm Reduction
Document Type
e-Resolutions
December 2022
EB41/R3 – Extension of the invitation to Japan to occupy the temporary Executive Board seat
Document Type
Resolutions
December 2022
EB41/R1 – Area for Intervention: “Mitigating antimalarial drug resistance”
Document Type
Resolutions
December 2022
R19-2022-e Calendar of Board and Committee meetings for 2023
Document Type
e-Resolutions
August 2022
R18-2022-e Amended Calendar of Board and Committee meetings for 2022
Document Type
e-Resolutions
August 2022
R17-2022-e Cost Extension for the Project ‘Better Access to Treatment for Paediatric MDR-TB (BENEFIT Kids)’
Document Type
e-Resolutions
August 2022
R16-2022-e DRIVEDX4TB: Accelerating Tools to Drive Tuberculosis Detection
Document Type
e-Resolutions
August 2022
R15-2022-e START 4-All: Start Taking Action for TB Diagnosis Project
Document Type
e-Resolutions
July 2022
R14-2022-e Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haemorrhage
Document Type
e-Resolutions
July 2022
R13-2022-e TRANSFORM: Increasing equitable access to tranexamic acid to reduce deaths from postpartum haemorrhage Project
Document Type
e-Resolutions
July 2022
R12-2022-e AMPLI-PPHI: Accelerating Measurable Progress and Leveraging Investments for PPH Impact Project
Document Type
e-Resolutions
No results could be found. Try refining your filters.
No results could be found. Try refining your filters.
No results could be found. Try refining your filters.
July 2021
End-of-Project Evaluation of the HIV Self-Testing AfRica (STAR) Initiative
Document Type
Evaluations
July 2021
Screening and treatment for Chagas disease – technology and market landscape
Document Type
Technical Reports
June 2021
Unitaid Audited Financial Report for the year ended 31 December 2020
Document Type
Financial Statement
May 2021
Biomarkers for acute febrile illness at the point-of-care in low-resource settings. Technical working session. Meeting pre-reads
Document Type
May 2021
Biomarkers for acute febrile illness at the point-of-care in low-resource settings. Meeting report
Document Type
February 2021
Accelerating Access to Innovative Point-of-Care HIV Diagnostics – Lessons learned from UNICEF
Document Type
Booklets
October 2020
Innovative delivery systems for paediatric medicines technology landscape
Document Type
Technology Landscape
June 2020
Unitaid Audited Financial Report for the year ended 31 December 2019
Document Type
Financial Statement
April 2020
End of project evaluation: Market entry of improved paediatric protease inhibitor-based fixed-dose combination for children with HIV/AIDS
Document Type
Evaluations